Comparative pharmacology of cholecystokinin induced activation of cultured vagal afferent neurons from rats and mice.
Cholecystokinin (CCK) facilitates the process of satiation via activation of vagal afferent neurons innervating the upper gastrointestinal tract. Recent findings indicate CCK acts on these neurons via a ruthenium red (RuR) sensitive pathway that involves members of the vanilloid (V) subfamily of tra...
Guardado en:
Autores principales: | Dallas C Kinch, James H Peters, Steven M Simasko |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/33b16dc9148c46ab81b33963b378ed8e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management
por: Amandine Bernard, et al.
Publicado: (2021) -
GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose
por: Yusaku Iwasaki, et al.
Publicado: (2018) -
Neuronal heterogeneity and stereotyped connectivity in the auditory afferent system
por: Charles Petitpré, et al.
Publicado: (2018) -
Fibroblast Growth Factor 19 Increases the Excitability of Pre-Motor Glutamatergic Dorsal Vagal Complex Neurons From Hyperglycemic Mice
por: Jordan B. Wean, et al.
Publicado: (2021) -
Age is associated with reduced urethral pressure and afferent activity in rat
por: Arezoo Geramipour, et al.
Publicado: (2021)